Abstract
This paper describes a study of the content of total phenolic contents, the antioxidant capacity and the cyclic voltammetry of Zilla macroptera aqueous extract. The results demonstrate that the content of total phenolics was 89±2.46 g of Gallic acid equivalence per 1 mg of extract and the content of total flavonoids was 12.99±0.67 µg of Quercetin equivalency per 1 mg of extract. Four methods ‘‘in vitro’’ were used to evaluate the antioxidant capacity of Zilla macroptera aqueous extract. The reducing power test showed that the sample has an equivalent activity of 63.16±1.09 µg of Ascorbic acid for 1 mg of extract. The total antioxidant capacity presented an equivalent capacity of 25±0.94 µg of Ascorbic acid per 1 mg of extract. The voltammogram indicates two potentials oxidation peaks; 0.6 V and 0.92 V towards the reference electrode (Ag / AgCl).
Keywords: Antioxidant capacity, cyclic voltammetry, reducing power, total flavonoids, total phenolics, Zilla macroptera.
Graphical Abstract
Current Bioactive Compounds
Title:Total Antioxidant Capacity, Reducing Power and Cyclic Voltammetry of Zilla Macroptera (Brassicaceae) Aqueous Extract
Volume: 12 Issue: 1
Author(s): Fatah Keffous, Nasser Belboukhari, Houria Djaradi, Abdelkrim Cheriti, Khaled Sekkoum and Hassan Y. Aboul-Enein
Affiliation:
Keywords: Antioxidant capacity, cyclic voltammetry, reducing power, total flavonoids, total phenolics, Zilla macroptera.
Abstract: This paper describes a study of the content of total phenolic contents, the antioxidant capacity and the cyclic voltammetry of Zilla macroptera aqueous extract. The results demonstrate that the content of total phenolics was 89±2.46 g of Gallic acid equivalence per 1 mg of extract and the content of total flavonoids was 12.99±0.67 µg of Quercetin equivalency per 1 mg of extract. Four methods ‘‘in vitro’’ were used to evaluate the antioxidant capacity of Zilla macroptera aqueous extract. The reducing power test showed that the sample has an equivalent activity of 63.16±1.09 µg of Ascorbic acid for 1 mg of extract. The total antioxidant capacity presented an equivalent capacity of 25±0.94 µg of Ascorbic acid per 1 mg of extract. The voltammogram indicates two potentials oxidation peaks; 0.6 V and 0.92 V towards the reference electrode (Ag / AgCl).
Export Options
About this article
Cite this article as:
Keffous Fatah, Belboukhari Nasser, Djaradi Houria, Cheriti Abdelkrim, Sekkoum Khaled and Y. Aboul-Enein Hassan, Total Antioxidant Capacity, Reducing Power and Cyclic Voltammetry of Zilla Macroptera (Brassicaceae) Aqueous Extract, Current Bioactive Compounds 2016; 12 (1) . https://dx.doi.org/10.2174/1573407212666160210230707
DOI https://dx.doi.org/10.2174/1573407212666160210230707 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subject Index To Volume 2
Current Respiratory Medicine Reviews Drug-Like Inhibitors of Protein-Protein Interactions: A Structural Examination of Effective Protein Mimicry
Current Protein & Peptide Science Sex Hormones, Metabolic Syndrome and Kidney
Current Topics in Medicinal Chemistry Vitamin D Intervention Trials in Critical Illness
Inflammation & Allergy - Drug Targets (Discontinued) Telomerase Therapeutics for Degenerative Diseases
Current Molecular Medicine Personalized and Participatory Medicine as a Future Tool to Combat Cardiovascular Disease in Developing Countries
Current Pharmacogenomics and Personalized Medicine Editorial [Hot Topic:Nicotinamide Adenine Dinucleotide Biology and Disease(Executive Editor: W. Todd Penberthy)]
Current Pharmaceutical Design Mitochondrial Oxidative Stress and Heart Failure ∼Novel Pathophysiological Insight and Treatment Strategies∼
Current Cardiology Reviews CTLA-4Ig: Uses and Future Directions
Recent Patents on Inflammation & Allergy Drug Discovery Physiological Roles for K posative Channels and Gap Junctions in Urogenital Smooth Muscle Implications for Improved Understanding of Urogenital Function, Disease and Therapy
Current Drug Targets Inflammation, Oxidative Stress and Metabolic Syndrome: Dietary Modulation
Current Vascular Pharmacology Fetal Arterial Changes in Response to Maternal Cigarette Smoking: Revisiting the Natural History of the Earliest Stage of Atherosclerosis
Current Cardiology Reviews Lipid-Induced Modulation of Protective Signalling Pathways in Cardiovascular Disease: The Role of High Density Lipoproteins
Current Signal Transduction Therapy Inflammatory Systemic Biomarkers in Setting Acute Coronary Syndromes - Effects of the Diurnal Variation
Current Drug Targets Vitamin D status in coronary artery disease: association with IL-35 and TGF-β1 and disease severity
Endocrine, Metabolic & Immune Disorders - Drug Targets Prevalence, Diagnosis, and Treatment with 3 Different Statins of Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis in Military Personnel. Do Genetics Play a Role?
Current Vascular Pharmacology The Role of the Stress-Related Anti-Inflammatory Hormones ACTH and Cortisol in Atherosclerosis
Current Vascular Pharmacology Reactive Oxygen Species in the Initiation of IL-4 Driven Autoimmunity as a Potential Therapeutic Target
Current Pharmaceutical Design Protrhombotic Effects of Contraceptives
Current Pharmaceutical Design Restoration of Cardiomyocyte Function in Streptozotocin-Induced Diabetic Rats after Treatment with Vanadate in a Tea Decoction
Current Pharmaceutical Biotechnology